289 related articles for article (PubMed ID: 27068735)
1. Testosterone Replacement Therapy and BPH/LUTS. What is the Evidence?
Baas W; Köhler TS
Curr Urol Rep; 2016 Jun; 17(6):46. PubMed ID: 27068735
[TBL] [Abstract][Full Text] [Related]
2. Testosterone and the Prostate: Artifacts and Truths.
DeLay KJ; Kohler TS
Urol Clin North Am; 2016 Aug; 43(3):405-12. PubMed ID: 27476133
[TBL] [Abstract][Full Text] [Related]
3. Testosterone replacement therapy and voiding dysfunction.
Baas W; Köhler TS
Transl Androl Urol; 2016 Dec; 5(6):890-897. PubMed ID: 28078221
[TBL] [Abstract][Full Text] [Related]
4. Testosterone supplementation does not worsen lower urinary tract symptoms.
Pearl JA; Berhanu D; François N; Masson P; Zargaroff S; Cashy J; McVary KT
J Urol; 2013 Nov; 190(5):1828-33. PubMed ID: 23764078
[TBL] [Abstract][Full Text] [Related]
5. Effects of Testosterone Replacement Therapy on Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis.
Kohn TP; Mata DA; Ramasamy R; Lipshultz LI
Eur Urol; 2016 Jun; 69(6):1083-90. PubMed ID: 26874809
[TBL] [Abstract][Full Text] [Related]
6. A new experimental rat model of erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia: the testosterone-supplemented spontaneously hypertensive rat.
Oudot A; Oger S; Behr-Roussel D; Caisey S; Bernabé J; Alexandre L; Giuliano F
BJU Int; 2012 Nov; 110(9):1352-8. PubMed ID: 22448674
[TBL] [Abstract][Full Text] [Related]
7. Critical analysis of the relationship between sexual dysfunctions and lower urinary tract symptoms due to benign prostatic hyperplasia.
Gacci M; Eardley I; Giuliano F; Hatzichristou D; Kaplan SA; Maggi M; McVary KT; Mirone V; Porst H; Roehrborn CG
Eur Urol; 2011 Oct; 60(4):809-25. PubMed ID: 21726934
[TBL] [Abstract][Full Text] [Related]
8. Androgen replacement therapy contributes to improving lower urinary tract symptoms in patients with hypogonadism and benign prostate hypertrophy: a randomised controlled study.
Shigehara K; Sugimoto K; Konaka H; Iijima M; Fukushima M; Maeda Y; Mizokami A; Koh E; Origasa H; Iwamoto T; Namiki M
Aging Male; 2011 Mar; 14(1):53-8. PubMed ID: 21171937
[TBL] [Abstract][Full Text] [Related]
9. Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism.
Okada K; Miyake H; Ishida T; Sumii K; Enatsu N; Chiba K; Matsushita K; Fujisawa M
Am J Mens Health; 2018 Sep; 12(5):1403-1408. PubMed ID: 27256990
[TBL] [Abstract][Full Text] [Related]
10. Updates on androgen replacement therapy and lower urinary tract symptoms: a narrative review.
Al-Zoubi RM; Alwani M; Aboumarzouk OM; Elaarag M; Al-Qudimat AR; Ojha L; Yassin A
Aging Male; 2022 Dec; 25(1):234-241. PubMed ID: 36066424
[TBL] [Abstract][Full Text] [Related]
11. Testosterone treatment is not associated with increased risk of prostate cancer or worsening of lower urinary tract symptoms: prostate health outcomes in the Registry of Hypogonadism in Men.
Debruyne FM; Behre HM; Roehrborn CG; Maggi M; Wu FC; Schröder FH; Jones TH; Porst H; Hackett G; Wheaton OA; Martin-Morales A; Meuleman E; Cunningham GR; Divan HA; Rosen RC;
BJU Int; 2017 Feb; 119(2):216-224. PubMed ID: 27409523
[TBL] [Abstract][Full Text] [Related]
12. Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia.
Russo A; Capogrosso P; La Croce G; Ventimiglia E; Boeri L; Briganti A; Damiano R; Montorsi F; Salonia A
Expert Opin Drug Saf; 2016 Dec; 15(12):1661-1670. PubMed ID: 27232207
[TBL] [Abstract][Full Text] [Related]
13. The role of inflammation in lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) and its potential impact on medical therapy.
Ficarra V; Rossanese M; Zazzara M; Giannarini G; Abbinante M; Bartoletti R; Mirone V; Scaglione F
Curr Urol Rep; 2014 Dec; 15(12):463. PubMed ID: 25312251
[TBL] [Abstract][Full Text] [Related]
14. Testosterone and benign prostatic hyperplasia.
Jarvis TR; Chughtai B; Kaplan SA
Asian J Androl; 2015; 17(2):212-6. PubMed ID: 25337845
[TBL] [Abstract][Full Text] [Related]
15. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
Silva J; Silva CM; Cruz F
Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
[TBL] [Abstract][Full Text] [Related]
16. [Patient with TDS and lower urinary tract symptoms (LUTS)].
Romero-Otero J; García B; Jiménez Alcalde E; García Cruz E; Leibar Tamayo A; Rodríguez Antolín A
Arch Esp Urol; 2013 Sep; 66(7):657-62. PubMed ID: 24047623
[TBL] [Abstract][Full Text] [Related]
17. Inhaled anticholinergic agents and acute urinary retention in men with lower urinary tract symptoms or benign prostatic hyperplasia.
Vande Griend JP; Linnebur SA
Ann Pharmacother; 2012 Sep; 46(9):1245-9. PubMed ID: 22851743
[TBL] [Abstract][Full Text] [Related]
18. Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?
Chiang BJ; Kuo HC; Liao CH
Toxins (Basel); 2019 Sep; 11(9):. PubMed ID: 31546892
[TBL] [Abstract][Full Text] [Related]
19. Solifenacin/tamsulosin fixed-dose combination therapy to treat lower urinary tract symptoms in patients with benign prostatic hyperplasia.
Dimitropoulos K; Gravas S
Drug Des Devel Ther; 2015; 9():1707-16. PubMed ID: 25834406
[TBL] [Abstract][Full Text] [Related]
20. Impact of Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction in Men Taking Once-Daily Tadalafil 5 mg for Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia: An Integrated Analysis of Three Randomized Controlled Trials.
Mulhall JP; Brock GB; Glina S; Baygani S; Donatucci CF; Maggi M
J Sex Med; 2016 May; 13(5):843-51. PubMed ID: 27017071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
